Compounded Semaglutide for Medical Spas & Doctors | Supply Guide | MedClinic Partners

GLP's & Peptide Supply Strategies for Clinics

Compounded Semaglutide for Medical Spas and Doctors

Compounded semaglutide remains one of the most requested GLP's compounds for medical spas and prescribing doctors. Here is what you need to know about sourcing it compliantly.

M
MedClinic Partners Editorial TeamB2B Medical Supply & Compounding Experts
4 min read
Reviewed & updated:
Compounded Semaglutide for Medical Spas and Doctors — MedClinic Partners

Compounded Semaglutide for Medical Spas and Doctors

Semaglutide has become one of the defining compounds of the current era in medical aesthetics and weight management. For medical spas and prescribing doctors, it represents both a significant revenue opportunity and a compliance responsibility that cannot be taken lightly.

This post covers what you need to know about sourcing compounded semaglutide — the regulatory framework, the supply options, and the questions you should be asking any potential supply partner.

Why Compounded Semaglutide Remains in Demand

The branded GLP-1 medications (Ozempic, Wegovy, Rybelsus) have faced persistent supply shortages and access barriers that have left a significant gap in the market. Compounded semaglutide — prepared by licensed 503A and 503B facilities — has filled that gap for millions of patients.

For medical spas and prescribing doctors, compounded semaglutide offers:

  • Accessibility when branded products are unavailable or unaffordable
  • Dosing flexibility — custom strengths not available in branded formulations
  • Cost efficiency for patients who cannot access insurance coverage
  • Practice differentiation in a competitive market

The Regulatory Landscape: What Has Changed

The FDA's position on compounded semaglutide has evolved significantly. During the shortage period, compounding was explicitly permitted. As shortage designations have been updated, the rules have shifted.

Here is what matters for your practice right now:

503A Compounding

Under 503A, compounded semaglutide can be prepared for individual patients with a valid prescription and a documented patient-prescriber relationship. The key requirements:

  • Valid prescription for a named patient
  • Licensed prescriber with an established patient relationship
  • State-licensed compounding pharmacy
  • Appropriate documentation

503B Outsourcing

503B facilities can supply compounded semaglutide for office use to healthcare facilities, including medical spas and physician offices, without patient-specific prescriptions — subject to FDA registration and CGMP compliance.

The Compliance Risk

The biggest risk for medical spas and doctors is sourcing from suppliers who are not operating within the appropriate regulatory framework. Non-compliant sourcing exposes your practice to:

  • DEA and state board investigations
  • Civil liability
  • Loss of licensure
  • Patient safety risks

Work with a supply partner that has the legal expertise to navigate these rules — not just a vendor who tells you what you want to hear.

Formulations Available

Compounded semaglutide is available in several formulations depending on your patient population and practice model:

Injectable vials — the most common form for weight management protocols. Available in multiple strengths (2.5 mg/mL, 5 mg/mL, 10 mg/mL, and custom on request).

Sublingual troches — an alternative for patients who prefer non-injectable administration. Useful for practices that want to offer a broader range of options.

What to Look for in a Supply Partner

If you are a medical spa or prescribing doctor sourcing compounded semaglutide, these are the questions that matter:

1. Are they 503A, 503B, or both? The answer determines what you can legally order and how. A partner that offers both gives you maximum flexibility.

2. What are the BUD dates? Short BUD dates create inventory management problems. Look for a partner that can offer up to 12-month BUD dates on select preparations.

3. Can they do custom orders? Not every patient fits a standard formulation. Custom strength and volume capability matters.

4. What is their COA process? Every lot should come with a certificate of analysis from an independent third-party lab. No exceptions.

5. What is their legal and compliance background? In a rapidly shifting regulatory environment, your supply partner's legal expertise is part of your compliance infrastructure.

6. Can you reach them 24/7? When a compliance question comes up or a patient needs product urgently, you need a partner who picks up the phone.

How MedClinic Partners Handles Semaglutide Supply

Semaglutide is our highest-volume product. We supply it through both 503A (patient-specific) and 503B (bulk office-use) channels, which means we can serve any practice model.

  • Injectable vials and sublingual troches
  • Multiple strengths including custom on request
  • Up to 12-month BUD dates
  • COA on every lot
  • Overnight shipping when in stock
  • Licensed in all 50 states
  • Founded by mass-tort attorneys with 15+ years of pharmaceutical litigation experience

Request portal access to order compounded semaglutide →

For licensed medical providers only. This content is for informational purposes and does not constitute legal or medical advice. Consult with qualified legal counsel regarding your specific compliance obligations.

Explore Topics

#semaglutide#GLP's#medical spa#compounding#503A#503B
M

Written by

MedClinic Partners Editorial Team

B2B Medical Supply & Compounding Experts

The MedClinic Partners editorial team is composed of licensed medical operators, compounding compliance specialists, and mass-tort attorneys with direct experience running GLP-1 and peptide programs across all 50 states. Every article is reviewed for clinical accuracy, regulatory compliance, and practical applicability before publication.

503A/503B CompoundingGLP-1 ProtocolsRegulatory ComplianceMedical Practice Operations

Editorial standards: All content on medclinicpartners.com is reviewed by licensed medical operators and compounding compliance specialists before publication. Articles are updated when regulatory guidance changes. This content is for licensed healthcare providers only and does not constitute medical advice.

For Licensed Providers

Ready to access 503A/503B supply + peptides?

Submit your info and we'll help connect you with the right compounding and research peptide partners for your practice.